Comprehensive evaluation of the test for 5′‐/3′‐end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer

por Mitiushkina, Natalia V., Romanko, Alexandr A., Preobrazhenskaya, Elena V., Tiurin, Vladislav I., Ermachenkova, Tatiana I., Martianov, Alexandr S., Mulkidjan, Rimma S., Sokolova, Tatiana N., Kholmatov, Maksim M., Bizin, Ilya V., Ivantsov, Alexandr O., Yatsuk, Olga S., Zaitseva, Olga A., Iyevleva, Aglaya G., Kuligina, Ekatherina Sh., Imyanitov, Evgeny N.
Publicado 2022

Large family with both parents affected by distinct BRCA1 mutations: implications for genetic testing

por Sokolenko, Anna P, Voskresenskiy, Dmitry A, Iyevleva, Aglaya G, Bit-Sava, Elena M, Gutkina, Nadezhda I, Anisimenko, Maxim S, Yu Sherina, Nathalia, Mitiushkina, Nathalia V, Ulibina, Yulia M, Yatsuk, Olga S, Zaitseva, Olga A, Suspitsin, Evgeny N, Togo, Alexandr V, Pospelov, Valery A, Kovalenko, Sergey P, Semiglazov, Vladimir F, Imyanitov, Evgeny N
Publicado 2009

High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients

por Suspitsin, Evgeny N, Sherina, Nathalia Yu, Ponomariova, Daria N, Sokolenko, Anna P, Iyevleva, Aglaya G, Gorodnova, Tatyana V, Zaitseva, Olga A, Yatsuk, Olga S, Togo, Alexandr V, Tkachenko, Nathalia N, Shiyanov, Grigory A, Lobeiko, Oksana S, Krylova, Nadezhda Yu, Matsko, Dmitry E, Maximov, Sergey Ya, Urmancheyeva, Adel F, Porhanova, Nathalia V, Imyanitov, Evgeny N
Publicado 2009